Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
1-Year Return 26.64%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
+4.71%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$219B
AUM Growth
+$3.8B
Cap. Flow
-$2.78B
Cap. Flow %
-1.27%
Top 10 Hldgs %
22.26%
Holding
1,666
New
289
Increased
589
Reduced
627
Closed
113

Sector Composition

1 Technology 30.51%
2 Healthcare 19.12%
3 Consumer Discretionary 11.48%
4 Financials 10.31%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ECOM
526
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$54.4M 0.02%
2,311,019
+11,776
+0.5% +$277K
ITRI icon
527
Itron
ITRI
$5.43B
$54.2M 0.02%
611,776
-199,121
-25% -$17.7M
DRVN icon
528
Driven Brands
DRVN
$3.04B
$54.2M 0.02%
+2,133,636
New +$54.2M
RPRX icon
529
Royalty Pharma
RPRX
$15.8B
$54.1M 0.02%
1,240,054
-3,661,646
-75% -$160M
MDLZ icon
530
Mondelez International
MDLZ
$81B
$53.9M 0.02%
920,438
+213,126
+30% +$12.5M
ACCD
531
DELISTED
Accolade, Inc. Common Stock
ACCD
$53.8M 0.02%
1,186,658
+224,648
+23% +$10.2M
SKY icon
532
Champion Homes, Inc.
SKY
$4.21B
$53.8M 0.02%
1,189,255
+329,046
+38% +$14.9M
LYFT icon
533
Lyft
LYFT
$7.63B
$53.1M 0.02%
840,546
+820,446
+4,082% +$51.8M
AMBA icon
534
Ambarella
AMBA
$3.61B
$52.7M 0.02%
525,811
-414,407
-44% -$41.6M
BCAB icon
535
BioAtla
BCAB
$41.9M
$52.5M 0.02%
1,032,413
-283,764
-22% -$14.4M
CSII
536
DELISTED
Cardiovascular Systems, Inc.
CSII
$52.5M 0.02%
1,369,000
-311
-0% -$11.9K
CCCS icon
537
CCC Intelligent Solutions
CCCS
$6.28B
$52.3M 0.02%
+5,156,480
New +$52.3M
BIO icon
538
Bio-Rad Laboratories Class A
BIO
$7.74B
$52.3M 0.02%
91,524
+34,635
+61% +$19.8M
SHC icon
539
Sotera Health
SHC
$4.49B
$52.2M 0.02%
2,092,926
-1,411,424
-40% -$35.2M
CRTO icon
540
Criteo
CRTO
$1.21B
$51.8M 0.02%
1,490,003
-424,672
-22% -$14.8M
XOM icon
541
Exxon Mobil
XOM
$472B
$51.8M 0.02%
927,249
-85,907
-8% -$4.8M
KSU
542
DELISTED
Kansas City Southern
KSU
$51.6M 0.02%
195,675
-216,160
-52% -$57M
GPK icon
543
Graphic Packaging
GPK
$6.08B
$51.6M 0.02%
2,841,246
-647,978
-19% -$11.8M
CHDN icon
544
Churchill Downs
CHDN
$6.85B
$51.2M 0.02%
450,702
-85,752
-16% -$9.75M
DD icon
545
DuPont de Nemours
DD
$32.1B
$51.1M 0.02%
661,102
+257,114
+64% +$19.9M
FDMT icon
546
4D Molecular Therapeutics
FDMT
$326M
$50.7M 0.02%
1,227,397
+205,486
+20% +$8.49M
BCYC
547
Bicycle Therapeutics
BCYC
$493M
$50.7M 0.02%
+1,693,658
New +$50.7M
CTVA icon
548
Corteva
CTVA
$49.2B
$50.6M 0.02%
1,084,782
-61,418
-5% -$2.86M
FOX icon
549
Fox Class B
FOX
$23.6B
$50.2M 0.02%
1,436,600
-529,917
-27% -$18.5M
XEL icon
550
Xcel Energy
XEL
$42.6B
$50.1M 0.02%
753,660
-540,862
-42% -$36M